Clinical Trials Logo
  1. Home
  2. Stable Angina Pectoris
  3. NCT00638326

Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity — DOSER  

Stable Angina Pectoris Clinical Trial

Official title:
150 mg Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity After Elective Percutaneous Coronary Intervention

Clinical Trial Summary

The purpose of the study is to determine whether administration of 150 mg clopidogrel is effective in reducing the one-year incidence of thromboischemic events in patients with high on-clopidogrel platelet reactivity compared to 75 mg clopidogrel after elective percutaneous coronary intervention.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00638326
Study type Interventional
Source University of Pecs
Contact
Status Terminated
Phase Phase 3
Start date March 2008
Completion date March 2010
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01257282 - Prevalence and Prognostic Value of Unrecognized Myocardial Injury in Stable Coronary Artery Disease (PUMI) N/A
Completed NCT02294942 - Extended-Release RANCAD in the Patients With Stable Angina Pectoris Phase 3
Completed NCT02029118 - Acupoint Application in Patients With Stable Angina Pectoris (AASAP) Early Phase 1
Completed NCT00763464 - Coronary Artery Disease (CAD) in Postmenopausal Women N/A
Recruiting NCT02328898 - Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent Phase 4
Completed NCT02339454 - Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris Phase 3
Completed NCT01502943 - Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index Phase 4
Withdrawn NCT02165670 - BASIC VALIDATE Coronary Stent Registry
Completed NCT01632371 - Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4 Phase 4
Completed NCT01363661 - Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris Phase 4
Completed NCT01293097 - Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI Phase 4
Completed NCT02747329 - A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT N/A
Recruiting NCT05347069 - Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Phase 4
Recruiting NCT04938661 - Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) N/A
Not yet recruiting NCT03155971 - PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial) N/A
Active, not recruiting NCT02285322 - Predictors of Blood Pressure Control and Associations With Cardiovascular Diseases in Individuals With High Blood Pressure: a CALIBER Study N/A
Active, not recruiting NCT02062021 - Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease N/A
Active, not recruiting NCT01947361 - Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber) N/A
Active, not recruiting NCT01937065 - Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study N/A
Completed NCT01669382 - Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites Phase 3